Bli medlem
Bli medlem

Du är här


Redeye: Vertiseit Q2’2021 Review - New Targets Ahead

Redeye raises its Base case for Vertiseit following its Q2 report, despite a mixed outcome. However, we believe the long-term prospects in embracing Grassfish strategy are favorable, resulting in a more SaaS-like company with a sales mix dominated by SaaS and Agency/Consultancy.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking.


Vertiseit Q2’2021 Review - New Targets Ahead

Författare MFN